BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1471460)

  • 1. Malignant prolactinoma.
    Berezin M; Gutman I; Tadmor R; Horowitz A; Findler G
    Acta Endocrinol (Copenh); 1992 Nov; 127(5):476-80. PubMed ID: 1471460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant prolactinoma: case report and review of the literature.
    Popadić A; Witzmann A; Buchfelder M; Eiter H; Komminoth P
    Surg Neurol; 1999 Jan; 51(1):47-54; discussion 54-5. PubMed ID: 9952123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments of multi-invasive giant prolactinoma.
    Yang MY; Shen CC; Ho WL
    J Clin Neurosci; 2004 Jan; 11(1):70-5. PubMed ID: 14642373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of large prolactinoma supposed to be cured by bromocriptine therapy.
    Arita K; Uozumi T; Ohta M
    Endocrinol Jpn; 1988 Jun; 35(3):503-9. PubMed ID: 3197661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant invasive prolactinoma: a case report and review of nine further cases.
    Davis JR; Sheppard MC; Heath DA
    Q J Med; 1990 Mar; 74(275):227-38. PubMed ID: 2385731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of radiotherapy and bromocriptine treatment in patients with previous surgery for macroprolactinomas.
    Moberg E; af Trampe E; Wersäll J; Werner S
    Neurosurgery; 1991 Aug; 29(2):200-4; discussion 204-5. PubMed ID: 1886657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of prolactin-secreting pituitary adenomas.
    Neal JH; Weiss MH
    West J Med; 1990 Nov; 153(5):546-7. PubMed ID: 2260295
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas.
    Mon SY; Alkabbani A; Hamrahian A; Thorton JN; Kennedy L; Weil R; Olansky L; Doshi K; Makin V; Hatipoglu B
    Pituitary; 2013 Dec; 16(4):523-7. PubMed ID: 23203499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin decrease and shift to a normal-like isoform profile during treatment with quinagolide in a patient affected by an invasive prolactinoma.
    Guido R; Valenti S; Foppiani L; De Martini D; Cossu M; Giusti M
    J Endocrinol Invest; 1997 May; 20(5):289-93. PubMed ID: 9258810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant pituitary prolactinoma with falsely low serum prolactin: the pitfall of the "high-dose hook effect": case report.
    Barkan AL; Chandler WF
    Neurosurgery; 1998 Apr; 42(4):913-5; discussion 915-6. PubMed ID: 9574657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactinoma.
    Serri O; Beauregard H; Somma M
    Curr Ther Endocrinol Metab; 1994; 5():41-3. PubMed ID: 7704764
    [No Abstract]   [Full Text] [Related]  

  • 13. Does normalization of prolactin levels result in weight loss in patients with prolactin secreting pituitary adenomas?
    Yermus R; Ezzat S
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):562. PubMed ID: 11966752
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of prolactinomas during pregnancy].
    Chen W; Bian X; Gai M; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):335-7. PubMed ID: 12126566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
    Barrera CM; Ruiz AE; Banks WA
    Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hypophyseal prolactin-secreting macroadenomas].
    Candrina R; Tosoni M
    Recenti Prog Med; 1989 Sep; 80(9):471-3. PubMed ID: 2595078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant prolactinomas: the therapeutic approach.
    Moraes AB; Silva CM; Vieira Neto L; Gadelha MR
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):447-56. PubMed ID: 23662975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of hyperprolactinemia with pergolide.
    Mattox JH; Bernstein J; Buckman MT
    Int J Fertil; 1986; 30(4):39-43. PubMed ID: 2890594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orbital invasion with prolactinoma: a clinical review of four patients.
    Karcioglu ZA; Aden LB; Cruz AA; Zaslow L; Saloom RJ
    Ophthalmic Plast Reconstr Surg; 2002 Jan; 18(1):64-71. PubMed ID: 11910327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.